| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 439 | 2021 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 328 | 2021 |
| Tocilizumab for treatment of severe COVID-19 patients: preliminary results from SMAtteo COvid19 REgistry (SMACORE) M Colaneri, L Bogliolo, P Valsecchi, P Sacchi, V Zuccaro, F Brandolino, ... Microorganisms 8 (5), 695, 2020 | 227 | 2020 |
| Persistence of SARS-CoV-2-specific B and T cell responses in convalescent COVID-19 patients 6–8 months after the infection N Sherina, A Piralla, L Du, H Wan, M Kumagai-Braesch, J Andréll, ... Med 2 (3), 281-295. e4, 2021 | 205 | 2021 |
| Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 M Colaneri, P Sacchi, V Zuccaro, S Biscarini, M Sachs, S Roda, TC Pieri, ... Eurosurveillance 25 (16), 2000460, 2020 | 190 | 2020 |
| Severe acute respiratory syndrome coronavirus 2 RNA contamination of inanimate surfaces and virus viability in a health care emergency unit M Colaneri, E Seminari, S Novati, E Asperges, S Biscarini, A Piralla, ... Clinical Microbiology and Infection 26 (8), 1094. e1-1094. e5, 2020 | 159 | 2020 |
| The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies J Manry, P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, ... Proceedings of the National Academy of Sciences 119 (21), 2022 | 128 | 2022 |
| SARS Cov-2 infection in a renal-transplanted patient: A case report E Seminari, M Colaneri, M Sambo, I Gallazzi, A Di Matteo, S Roda, ... American Journal of Transplantation 20 (7), 1882-1884, 2020 | 94 | 2020 |
| EBV DNA increase in COVID-19 patients with impaired lymphocyte subpopulation count S Paolucci, I Cassaniti, F Novazzi, L Fiorina, A Piralla, G Comolli, R Bruno, ... International Journal of Infectious Diseases 104, 315-319, 2021 | 90 | 2021 |
| Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy M Colaneri, E Seminari, A Piralla, V Zuccaro, A Di Filippo, F Baldanti, ... Journal of Hospital Infection 105 (3), 474-476, 2020 | 81 | 2020 |
| The obesity paradox: Analysis from the SMAtteo COvid-19 REgistry (SMACORE) cohort S Biscarini, M Colaneri, S Ludovisi, E Seminari, TC Pieri, P Valsecchi, ... Nutrition, Metabolism and Cardiovascular Diseases 30 (11), 1920-1925, 2020 | 75 | 2020 |
| Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, adult patients: a systematic review with qualitative evidence synthesis M Bassetti, DR Giacobbe, C Grecchi, C Rebuffi, V Zuccaro, L Scudeller, ... Journal of Infection 81 (1), 131-146, 2020 | 68 | 2020 |
| Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUN gal infections Definitions in ICU patients … M Bassetti, L Scudeller, DR Giacobbe, F Lamoth, E Righi, V Zuccaro, ... Mycoses 62 (4), 310-319, 2019 | 64 | 2019 |
| Direct‐acting antivirals in hepatitis C virus‐associated diffuse large B‐cell lymphomas M Merli, M Frigeni, L Alric, C Visco, C Besson, L Mannelli, A Di Rocco, ... The Oncologist 24 (8), e720-e729, 2019 | 63 | 2019 |
| Myocarditis in a 16-year-old boy positive for SARS-CoV-2 M Gnecchi, F Moretti, EM Bassi, S Leonardi, R Totaro, L Perotti, V Zuccaro, ... The Lancet 395 (10242), e116, 2020 | 62 | 2020 |
| Beyond the gut bacterial microbiota: The gut virome P Columpsi, P Sacchi, V Zuccaro, S Cima, C Sarda, M Mariani, A Gori, ... Journal of medical virology 88 (9), 1467-1472, 2016 | 61 | 2016 |
| SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay I Cassaniti, E Percivalle, F Bergami, A Piralla, G Comolli, R Bruno, ... Clinical Microbiology and Infection 27 (7), 1029-1034, 2021 | 60 | 2021 |
| Immunity to SARS-CoV-2 up to 15 months after infection H Marcotte, A Piralla, F Zuo, L Du, I Cassaniti, H Wan, M Kumagai-Braesh, ... IScience 25 (2), 2022 | 54 | 2022 |
| Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19 E Villa, R Critelli, S Lasagni, A Melegari, A Curatolo, C Celsa, ... Blood advances 5 (3), 662-673, 2021 | 54 | 2021 |
| Calcineurin inhibitor-based immunosuppression and COVID-19: results from a multidisciplinary cohort of patients in Northern Italy L Cavagna, E Seminari, G Zanframundo, M Gregorini, A Di Matteo, ... Microorganisms 8 (7), 977, 2020 | 54 | 2020 |
